http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E9%AB%98%E8%A1%80%E5%8E%8B-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-IRI 2026-04-28T21:00:41Z 本wiki的该页面的版本历史 MediaWiki 1.30.0 http://120.24.161.253:5617/index.php?title=%E9%AB%98%E8%A1%80%E5%8E%8B-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-IRI&diff=1270900&oldid=prev 2024-07-06T14:00:00Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 14:00的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E9%AB%98%E8%A1%80%E5%8E%8B-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-IRI&diff=1270901&oldid=prev 2024-07-06T09:29:16Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 09:29的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7" >第7行：</td> <td colspan="2" class="diff-lineno">第7行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===血清抵抗素水平与高血压的相关性（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===血清抵抗素水平与高血压的相关性（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>结果:[[高血压]]组患者其腰围,BMI,血压,[[IRI]],hsCRP和抵抗素水平较正常对照组高(均P<del class="diffchange diffchange-inline">&lt;</del>0.05),[[高血压]]组患者血清抵抗素与腰围、收缩压、[[IRI]]及hsCRP呈正相关(r值分别为0.391,0.425,0.608,0.447,均P<del class="diffchange diffchange-inline">&lt;</del>0.05),对照组血清</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>结果:[[高血压]]组患者其腰围,BMI,血压,[[IRI]],hsCRP和抵抗素水平较正常对照组高(均P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.05),[[高血压]]组患者血清抵抗素与腰围、收缩压、[[IRI]]及hsCRP呈正相关(r值分别为0.391,0.425,0.608,0.447,均P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.05),对照组血清</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===高血压病患者血清chemerin与胰岛素抵抗及炎症的关系（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===高血压病患者血清chemerin与胰岛素抵抗及炎症的关系（中华医学会文献）===</div></td></tr> </table>

KGadmin http://120.24.161.253:5617/index.php?title=%E9%AB%98%E8%A1%80%E5%8E%8B-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-IRI&diff=203543&oldid=prev 2021-10-21T07:56:14Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2021年10月21日 (四) 07:56的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E9%AB%98%E8%A1%80%E5%8E%8B-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-IRI&diff=203538&oldid=prev 2021-10-19T13:56:59Z

<p>修改1</p> <p><b>新页面</b></p><div>主实体：[[高血压]]，关系：[[实验室检查]] ，尾实体：[[IRI]]<br /> <br /> 实体ID:''431016''<br /> ==关系介绍==<br /> 待补充<br /> <br /> ==来源==<br /> ===血清抵抗素水平与高血压的相关性（中华医学会文献）===<br /> 结果:[[高血压]]组患者其腰围,BMI,血压,[[IRI]],hsCRP和抵抗素水平较正常对照组高(均P&lt;0.05),[[高血压]]组患者血清抵抗素与腰围、收缩压、[[IRI]]及hsCRP呈正相关(r值分别为0.391,0.425,0.608,0.447,均P&lt;0.05),对照组血清<br /> <br /> ===高血压病患者血清chemerin与胰岛素抵抗及炎症的关系（中华医学会文献）===<br /> 结果 [[高血压]]家族史、腰围、血压、空腹胰岛素[[IRI]]、hsCRP及Chemerin在[[高血压]]组和对照组之间差异有统计学意义(P＜0.05),血清chemerin与各指标作相关分析结果显示:[[高血压]]组患者血清chemerin与hsCRP、空腹胰岛素、[[IRI]]、血肌酐、<br /> <br /> ===血浆Apelin水平与冠心病及胰岛素抵抗的关系研究（中华医学会文献）===<br /> 结果 2组[[高血压]]病史及空腹胰岛素、[[IRI]]、hs-CRP以及Apelin水平比较差异均有统计学意义(P均＜0.05);观察组A患者[[IRI]]、hs-CRP明显高于观察组B(P均＞0.05),血浆Ape-lin水平显著低于观察组B(P ＜0.05);多因素分析显示</div>

Admin